Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROPHETIC Extended - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Extended Study.

NCT05736029 is registered in ClinicalTrials.gov with OncoHost Ltd. as lead sponsor.

NCT NCT05736029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05736029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROPHETIC Extended - Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Extended Study.
Lead sponsor
OncoHost Ltd.
Phase
Observational
Overall status
Recruiting
Start date
November 7, 2022
Completion date
June 30, 2028
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, non small cell lung cancer